Terms: = Uterine cancer AND NUTM2A, ENSG00000184923, Q5VT03, Q8IVF1, KIAA2020, 728118, FAM22A AND Treatment
4 results:
1. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract] [Full Text] [Related]
2. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy.
Libertini M; Hallin M; Thway K; Noujaim J; Benson C; van der Graaf W; Jones RL
Int J Surg Pathol; 2021 Feb; 29(1):4-20. PubMed ID: 32909482
[TBL] [Abstract] [Full Text] [Related]
3. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.
Hemming ML; Wagner AJ; Nucci MR; Chiang S; Wang L; Hensley ML; George S
Gynecol Oncol; 2017 Jun; 145(3):531-535. PubMed ID: 28390819
[TBL] [Abstract] [Full Text] [Related]
4. uterine sarcoma Part II-uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract] [Full Text] [Related]
